Form 4: Arteris CEO Charles Janac Sells Shares Under 10b5-1 Trading Plan

Arteris CEO Charles Janac sold a total of 71,109 shares of common stock in two transactions on December 30 and 31, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Charles Janac, the President and CEO of Arteris, Inc., sold shares of the company's common stock on December 30 and 31, 2024.
• The sales were executed under a pre-arranged 10b5-1 trading plan adopted on February 27, 2024.
• On December 30, 2024, 58,212 shares were sold at a weighted average price of $10.3257, with individual prices ranging from $10.00 to $10.53.
• On December 31, 2024, 12,897 shares were sold at a weighted average price of $10.2253, with individual prices ranging from $10.05 to $10.46.
• Following these transactions, Janac directly owns 274,776 shares and indirectly owns 10,007,691 shares through Bayview Legacy, LLC and 77,286 shares through the Charles and Lydia Janac Trust.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by an executive under a pre-arranged plan. It doesn't indicate any positive or negative sentiment about the company's performance.

Risks

• Sales by a company's CEO could be perceived negatively by the market, potentially impacting the stock price.

Industry Context

This is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates that the sales were pre-planned and not based on any non-public information.

Comparison to Industry Standards

• Sales by executives under 10b5-1 plans are a common practice in publicly traded companies, such as those in the technology sector like ARM Holdings or Synopsys, where executives often have significant stock holdings.
• The reported prices are within the typical trading range for Arteris stock, and the volume of shares sold is not unusual for an executive's pre-planned sales.
• Similar filings can be seen from executives at other companies, such as Cadence Design Systems, where executives regularly sell shares under similar plans.

Stakeholder Impact

• The stock sales by the CEO could potentially cause a slight decrease in the stock price due to increased supply, but the impact is likely to be minimal given the pre-planned nature of the sales.

Key Dates

Keywords

Arteris, Charles Janac, insider trading, 10b5-1 plan, stock sale, executive, share transaction, Bayview Legacy LLC, Charles and Lydia Janac Trust